loadpatents
Patent applications and USPTO patent grants for Mayumi; Tadanori.The latest application filed is for "tumor necrosis factor-alpha mutants".
Patent | Date |
---|---|
Human tumor necrosis factor-.alpha. mutants Grant 8,187,584 - Mayumi , et al. May 29, 2 | 2012-05-29 |
Tumor Necrosis Factor-alpha Mutants App 20110293555 - MAYUMI; TADANORI ;   et al. | 2011-12-01 |
Tumor necrosis factor-alpha mutants Grant 7,993,636 - Mayumi , et al. August 9, 2 | 2011-08-09 |
Cell permeable peptide Grant 7,989,588 - Nakagawa , et al. August 2, 2 | 2011-08-02 |
Cell Permeable Peptide App 20110045009 - Nakagawa; Shinsaku ;   et al. | 2011-02-24 |
TNF antagonist and TNF inhibitor containing it as an effective ingredient App 20100222258 - Mayumi; Tadanori | 2010-09-02 |
Mutant interferon .alpha. protein and use thereof Grant 7,666,403 - Mayumi , et al. February 23, 2 | 2010-02-23 |
mutant interferon alpha protein and use thereof App 20090311218 - Mayumi; Tadanori ;   et al. | 2009-12-17 |
Cancer Vaccine Comprising A Cancer Antigen Based On The Product Of A Tumor Suppressor Gene Wt1 And A Cationic Liposome App 20090098197 - MAYUMI; Tadanori ;   et al. | 2009-04-16 |
Tumor vessel endothelial cell-binding monoclonal antibodies Grant 7,189,824 - Mayumi , et al. March 13, 2 | 2007-03-13 |
Physiologically active complex Grant 7,179,891 - Mayumi , et al. February 20, 2 | 2007-02-20 |
Novel virus vector App 20060258005 - Mayumi; Tadanori ;   et al. | 2006-11-16 |
Cancer vaccine containing cancer antigen based on tumor suppressor gene wt1 product and cationic liposomes App 20060165708 - Mayumi; Tadanori ;   et al. | 2006-07-27 |
Method of intracellular sustained-release of drug and preparations Grant 6,875,448 - Mayumi , et al. April 5, 2 | 2005-04-05 |
Physiologically active complex App 20050013795 - Mayumi, Tadanori ;   et al. | 2005-01-20 |
Physiologically active complex App 20040001802 - Mayumi, Tadanori ;   et al. | 2004-01-01 |
Altering the properties of cells or of particles with menbranes derived from cells by means of lipid-modified proteinaceous molecules App 20020081305 - Mayumi, Tadanori ;   et al. | 2002-06-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.